These results demonstrate that Lgr5 expression is positively associated with the activity and expression of key molecules of the Wnt/β-catenin pathway in ESCC, implicating Lgr5 as an activator of the Wnt/β-catenin signaling pathway. The gene discussed is LGR5; the disease is esophageal squamous cell carcinoma.